Gastric Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Gastric Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-05-30Clinical Trial Update: Relationship Between Perioperative Treatment Efficacy and The Tumor Microenvironment for Locally Advanced Resectable Gastric Cancer.
This clinical trial update discusses how perioperative treatment efficacy may be influenced by the tumor microenvironment in locally advance…
-
CLINICAL_TRIALS research · 2025-05-28Clinical Trial Update: Neoadjuvant Chemo-hypoRT Plus PD-1 Antibody (Tislelizumab) in Resectable LA-G/GEJ [Phase 2]
This clinical trial update describes a Phase 2 study evaluating neoadjuvant chemotherapy and hypofractionated radiotherapy combined with the…
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: Adebrelimab With Chemoradiotherapy and Surgery for G/GEJ [Phase 2]
Phase 2 clinical trial evaluating Adebrelimab in combination with chemoradiotherapy and surgery for gastroesophageal junction and gastric ad…
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: Evaluating Novel Therapies in ctDNA Positive GI Cancers [Phase 3]
Georgetown University is conducting a Phase 3 trial evaluating novel therapies for ctDNA-positive gastrointestinal cancers, currently recrui…
-
CLINICAL_TRIALS research · 2025-05-06Clinical Trial Update: Total Neoadjuvant FLOT Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer [Phase 2, Phase 3]
A Phase 2/Phase 3 trial is evaluating total neoadjuvant FLOT chemotherapy for locally advanced gastric and gastroesophageal junction cancer;…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-04-27Clinical Trial Update: Combination of QLS31905, QL2107 and Chemotherapy as First-line Therapy in CLDN18.2-positive Unresectable Locally Advanced or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma [Phase 2]
Phase 2 study evaluating a combination of QLS31905, QL2107, and chemotherapy as first-line therapy for CLDN18.2-positive unresectable locall…
-
CLINICAL_TRIALS research · 2025-04-06Clinical Trial Update: Efficacy of Tirellizumab Combined With Oral, Intravenous and Abdominal Chemotherapy in Peritoneal Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma [Phase 2]
Phase 2 trial evaluating Tirellizumab combined with oral, IV, and intraperitoneal chemotherapy for gastric/gastroesophageal junction/esophag…
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: Fruquintinib Combined With PD-1 Inhibitor as First-line Maintenance Therapy for Advanced Gastric Cancer [Phase 2]
Phase 2 trial update evaluating fruquintinib in combination with a PD-1 inhibitor as first-line maintenance therapy for advanced gastric can…
-
CLINICAL_TRIALS research · 2025-03-18Clinical Trial Update: The Safety and Efficacy of Robotic Assisted Surgery Using Vessel Sealer Extend in Locally Advanced Gastric Cancer
This clinical trial update describes a study evaluating robotic-assisted surgery with Vessel Sealer Extend for locally advanced gastric canc…
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: Fruquintinib Combined With PD-1 Inhibitor and FOLFOX as First-Line Treatment For Advanced Gastric Cancer [Phase 1, Phase 2]
A clinical trial update describes a planned first-line treatment for advanced gastric cancer using Fruquintinib in combination with a PD-1 i…
-
CLINICAL_TRIALS research · 2025-03-04Clinical Trial Update: Postoperative Adjuvant Therapy for CT041 Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma Patients [Phase 1]
Phase 1 clinical trial evaluating CT041 as postoperative adjuvant therapy for gastric and gastroesophageal junction adenocarcinoma; the stud…
-
CLINICAL_TRIALS research · 2025-02-19Clinical Trial Update: Longitudinal Assessment of Biomarkers After Oesophagogastric Cancer Surgery
A longitudinal biomarker study in patients undergoing esophageal/gastric cancer surgery. Imperial College London is recruiting to profile bi…
-
CLINICAL_TRIALS research · 2025-01-29Clinical Trial Update: Different Cycles of Neoadjuvant PD-1 Blockades + Chemotherapy for Advanced Gastric Cancer
A clinical trial is evaluating different cycles of neoadjuvant PD-1 blockade plus chemotherapy for advanced gastric adenocarcinoma; recruitm…
-
CLINICAL_TRIALS research · 2025-01-07Clinical Trial Update: Second-line Treatment With Serplulimab, Lenvatinib, and Paclitaxel in Advanced Gastric Cancer After Prior Immunotherapy [Phase 2]
A phase 2 clinical trial is evaluating the combination of serplulimab, lenvatinib, and paclitaxel as second-line therapy for advanced gastri…
-
CLINICAL_TRIALS research · 2024-10-24Clinical Trial Update: Oxaliplatin ± Nivolumab in Combination With Trifluridine/Tipiracil or 5-fluorouracile in Frail Patients With Advanced, Recurrent or Metastatic Gastric, Oesophageal or Gastroesophageal Junction Cancer [Phase 2]
Phase 2 trial assessing oxaliplatin with or without nivolumab in combination with trifluridine/tipiracil or 5-fluorouracil for frail patient…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: A Study of Anti-PD-1 and LAG-3 Bispecific Antibody(AK129) Combined With Chemotherapy With or Without Cadonilimab in the First-line Treatment of Unresectable Locally Advanced or Metastatic G/ GEJ Adenocarcinoma [Phase 1, Phase 2]
A clinical trial update describes a Phase 1/2 study of AK129, an anti-PD-1 and LAG-3 bispecific antibody, combined with chemotherapy with or…
-
CLINICAL_TRIALS research · 2024-09-05Clinical Trial Update: A PhaseⅠ/Ⅱ Study of Simmitinib or Irinotecan Liposomes Combined With DP303c in Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma [Phase 1, Phase 2]
This clinical trial update describes a Phase I/II study evaluating Simmitinib or irinotecan liposomes in combination with DP303c for HER2-ex…
-
CLINICAL_TRIALS research · 2024-08-27Clinical Trial Update: A Randomized, Multicenter Phase II Basket Study of Hypofractionated Radiotherapy/Stereotactic Body Radiotherapy Followed by Immunotherapy-Based Systemic Therapy +/- L. Rhamnosus M9 for the First-Line Treatment of Advanced Digestive System Malignancies. [NA]
A multicenter Phase II basket trial at Zhejiang Cancer Hospital is evaluating hypofractionated radiotherapy or SBRT followed by immunotherap…
-
CLINICAL_TRIALS research · 2024-08-02Clinical Trial Update: Anti-PD-1 and CapOx for the First-line Treatment of dMMR Esophagogastric Cancer (AuspiCiOus) [Phase 2]
Phase 2 clinical trial evaluating a PD-1 inhibitor with Capecitabine and Oxaliplatin (CapOx) as first-line therapy for dMMR esophagogastric …
-
CLINICAL_TRIALS research · 2024-07-11Clinical Trial Update: Neoadjuvant Serplulimab in Combination With Chemotherapy in Locally Advanced Gastric or Gastro-esophageal Junction Cancer [Phase 2]
This Phase 2 trial is evaluating neoadjuvant serplulimab with chemotherapy for locally advanced gastric or gastroesophageal junction cancer.…
-
CLINICAL_TRIALS research · 2024-07-08Clinical Trial Update: Clinical Trial Evaluating FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab and Tremelimumab in Second-line Treatment of Patients With Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma [Phase 2]
A Phase 2 clinical trial is evaluating FOLFIRI plus Durvalumab versus FOLFIRI plus Durvalumab and Tremelimumab as second-line treatment for …
-
CLINICAL_TRIALS research · 2024-07-05Clinical Trial Update: Evaluation of Intra-operative Photographs for the Assessment of a Proper Lymphadenectomy in Minimally-invasive Gastrectomies for Gastric Cancer (PhotoNodes)
Clinical trial update describing a study (PhotoNodes) evaluating whether intra-operative photographs can assess the adequacy of lymphadenect…
-
CLINICAL_TRIALS research · 2024-06-27Clinical Trial Update: AK104 in Combination With AK112 Plus Chemotherapy(SOX/XELOX) as First-line Treatment for Advanced G/GEJ Cancer [Phase 2]
A Phase 2 trial is evaluating AK104 with AK112 and SOX/XELOX chemotherapy as first-line treatment for advanced gastric and gastroesophageal …
-
CLINICAL_TRIALS research · 2024-06-12Clinical Trial Update: Conversion Therapy of Sintilimab in Combination With Fruquintinib and Chemotherapy Versus Sintilimab and Chemotherpay in Stage IV Gastric Cancer [Phase 2]
A Phase 2 clinical trial is evaluating whether adding Fruquintinib to Sintilimab and chemotherapy improves outcomes versus Sintilimab and ch…
-
CLINICAL_TRIALS research · 2024-05-17Clinical Trial Update: Multimodal Rehabilitation on Gastric Adenocarcinoma Patients Following Radical D2 Gastrectomy [Phase 2]
Phase 2 clinical trial by Zhejiang Cancer Hospital evaluating multimodal rehabilitation for gastric cancer patients following radical D2 gas…